Answers are grounded in this paper and cite their sources.
Sacubitril/valsartan therapy has been found to reduce hospitalizations, improve echocardiogram parameters, and improve mortality in HFrEF. The objective is to assess S/V therapy effect on electrocardiogram indices and how those parameters related to echocardiographic parameters.
No takes yet. Share an insight, caveat, or question.
Allam et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: